LAVA THERAPEUTICS

Serial Number 79328096
Registration 6959490
700

Registration Progress

Application Filed
Sep 7, 2021
Under Examination
Approved for Publication
Nov 8, 2022
Published for Opposition
Nov 8, 2022
Registered
Jan 24, 2023

Trademark Image

LAVA THERAPEUTICS

Basic Information

Serial Number
79328096
Registration Number
6959490
Filing Date
September 7, 2021
Registration Date
January 24, 2023
Published for Opposition
November 8, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 24, 2023
Registration
Registered
Classes
044

Rights Holder

Lava Therapeutics N.V.

32
Address
Yalelaan 60
NL-3584 CM Utrecht
NL

Ownership History

Lava Therapeutics N.V.

Original Applicant
32
NL

Lava Therapeutics N.V.

Owner at Publication
32
NL

Lava Therapeutics N.V.

Original Registrant
32
NL

Legal Representation

Attorney
Robert R. Baron, Jr.

USPTO Deadlines

Next Deadline
1281 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-24)
Due Date
January 24, 2029
Grace Period Ends
July 24, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Sep 28, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 23, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 3, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 3, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 24, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 24, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 24, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 9, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 19, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 3, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 20, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 20, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 20, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 22, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
May 26, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 26, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 23, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 22, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 4, 2022 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Feb 26, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 19, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 19, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 19, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 19, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 19, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 14, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 9, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 044
Providing health information about the treatment or diagnosis of cancer, autoimmune diseases and immunological disorders via a website

Additional Information

Design Mark
The mark consists of the purple larger-sized stylized wording "LAVA", below which is the purple smaller-sized stylized wording "THERAPEUTICS". To the right of this is a tilted square with three lines breaking it up. The square is shaded from yellow to orange from top to bottom.
Color Claim
The color(s) purple, orange, and yellow is/are claimed as a feature of the mark.

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"